Lukas T Jeker

12PUBLICATIONS
132CO-AUTHORS
Regenerative medicine (incl. stem cells)Tumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)HaematologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Feb 21, 2026
Mast-cell derived nerve growth factor drives ILC2 pro-tumoral functions in bladder cancer.

Maryline Falquet, Hajar El Ahanidi, Alejandra Gomez-Cadena

|Dec 17, 2025
Single-amino acid variants in target epitopes can confer resistance to antibody-based therapies.

Romina Marone, Erblin Asllanaj, Giuseppina Capoferri

|May 22, 2024
Selective haematological cancer eradication with preserved haematopoiesis.

Simon Garaudé, Romina Marone, Rosalba Lepore

|Apr 17, 2024
Melanoma Clonal Heterogeneity Leads to Secondary Resistance after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes.

David König, Michael T Sandholzer, Sarp Uzun

|Mar 01, 2024
TGF-β specifies TFH versus TH17 cell fates in murine CD4+ T cells through c-Maf.

Yinshui Chang, Luisa Bach, Marko Hasiuk

Pageof 2